NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,099,670 | -20.3% | 109,244 | +5.4% | 0.00% | -33.3% |
| Q2 2023 | $2,634,961 | -4.7% | 103,657 | +35.5% | 0.01% | 0.0% |
| Q1 2023 | $2,766,306 | +177.0% | 76,523 | +203.5% | 0.01% | +200.0% |
| Q4 2022 | $998,554 | -19.2% | 25,216 | -4.9% | 0.00% | -33.3% |
| Q3 2022 | $1,236,000 | +191.5% | 26,523 | +173.9% | 0.00% | +200.0% |
| Q2 2022 | $424,000 | -74.9% | 9,684 | -58.6% | 0.00% | -66.7% |
| Q1 2022 | $1,691,000 | +175.0% | 23,375 | +207.9% | 0.00% | +200.0% |
| Q4 2021 | $615,000 | -64.1% | 7,591 | -48.5% | 0.00% | -66.7% |
| Q3 2021 | $1,715,000 | +35.1% | 14,739 | +92.6% | 0.00% | +50.0% |
| Q2 2021 | $1,269,000 | -2.4% | 7,653 | -17.9% | 0.00% | 0.0% |
| Q1 2021 | $1,300,000 | -54.7% | 9,319 | -43.8% | 0.00% | -60.0% |
| Q4 2020 | $2,869,000 | -14.0% | 16,574 | -30.8% | 0.01% | -16.7% |
| Q3 2020 | $3,335,000 | +10.5% | 23,939 | -5.3% | 0.01% | +20.0% |
| Q2 2020 | $3,019,000 | +116.9% | 25,274 | +81.5% | 0.01% | +150.0% |
| Q1 2020 | $1,392,000 | +26.9% | 13,922 | +49.2% | 0.00% | +100.0% |
| Q4 2019 | $1,097,000 | +293.2% | 9,332 | +167.4% | 0.00% | – |
| Q2 2018 | $279,000 | -11.7% | 3,490 | -4.2% | 0.00% | – |
| Q1 2018 | $316,000 | +21.1% | 3,642 | -3.6% | 0.00% | – |
| Q4 2017 | $261,000 | -37.7% | 3,779 | -18.0% | 0.00% | -100.0% |
| Q3 2017 | $419,000 | -60.1% | 4,607 | -67.4% | 0.00% | 0.0% |
| Q2 2017 | $1,051,000 | -1.5% | 14,117 | +24.0% | 0.00% | 0.0% |
| Q1 2017 | $1,067,000 | -11.7% | 11,386 | -31.6% | 0.00% | -50.0% |
| Q4 2016 | $1,209,000 | -29.1% | 16,635 | +1.8% | 0.00% | -33.3% |
| Q3 2016 | $1,706,000 | +74.1% | 16,340 | +23.0% | 0.00% | +50.0% |
| Q2 2016 | $980,000 | +31.0% | 13,289 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $748,000 | +16.7% | 13,289 | +40.0% | 0.00% | 0.0% |
| Q4 2015 | $641,000 | – | 9,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |